Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gene Expression Regulation, Neoplastic"" wg kryterium: Temat


Tytuł:
New insights into the regulation of METTL3 and its role in tumors.
Autorzy:
Jin Q; The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, 126 Xinmin Avenue, Changchun, Jilin, 130021, People's Republic of China.
Qu H; Department of Histology and Embryology, College of Basic Medical Sciences, Jilin University, 126 Xinmin Avenue, Changchun, Jilin, 130021, People's Republic of China. .
Quan C; The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, 126 Xinmin Avenue, Changchun, Jilin, 130021, People's Republic of China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2023 Nov 23; Vol. 21 (1), pp. 334. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Methyltransferases*/genetics
Gene Expression Regulation, Neoplastic*
RNA
Czasopismo naukowe
Tytuł:
LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma.
Autorzy:
Chen Y; Department of Neurosurgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 WeiWu Street, 450003, Zhengzhou, Zhengzhou, China.
Ma F; Department of Intensive Care Unit, The Third People's Hospital of Zhengzhou, Zhengzhou, China.
Zhang Z; Department of Neurosurgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 WeiWu Street, 450003, Zhengzhou, Zhengzhou, China.
Guo Y; Department of Neurosurgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 WeiWu Street, 450003, Zhengzhou, Zhengzhou, China.
Shen H; Department of Neurosurgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 WeiWu Street, 450003, Zhengzhou, Zhengzhou, China.
Chen H; Department of Neurosurgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 WeiWu Street, 450003, Zhengzhou, Zhengzhou, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 May 18; Vol. 23 (1), pp. 455. Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Temozolomide*/pharmacology
Temozolomide*/therapeutic use
Drug Resistance, Neoplasm*/genetics
Gene Expression Regulation, Neoplastic*/genetics
Glioma*/drug therapy
Glioma*/genetics
Glioma*/physiopathology
Gene Knockdown Techniques ; Carcinogenesis/genetics ; Survival Analysis ; STAT Transcription Factors/metabolism ; Janus Kinases/metabolism ; Cell Line, Tumor ; Humans ; Male ; Female ; Adult ; Middle Aged ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Epigenetics as a mediator of plasticity in cancer.
Autorzy:
Feinberg AP; Center for Epigenetics, Johns Hopkins University Schools of Medicine, Biomedical Engineering, and Public Health, Baltimore, MD 21205, USA.
Levchenko A; Yale Systems Biology Institute and Department of Biomedical Engineering, Yale University, West Haven, CT 06516, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Feb 10; Vol. 379 (6632), pp. eaaw3835. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Epigenesis, Genetic*
Neoplasms*/genetics
Neoplasms*/pathology
Gene Expression Regulation, Neoplastic*
Cell Plasticity*/genetics
Humans ; Cellular Senescence/genetics ; Carcinogenesis/genetics
Czasopismo naukowe
Tytuł:
YB-1 Expression Is Associated with Lymph Node Metastasis and Drug Resistance to Adriamycin in Breast Cancer.
Autorzy:
Dong H; Department of Medical Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
Jian Y; Department of Medical Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
Yu T; Department of Breast Surgery, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
Wang M; Department of Medical Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
Zhang W; Department of Infectious Diseases, The First Affiliated Hospital, Nanchang University, Nanchang, 330006 Jiangxi, China.
Peng Z; Department of Lymphohematology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2023 Feb 04; Vol. 2023, pp. 4667089. Date of Electronic Publication: 2023 Feb 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Gene Expression Regulation, Neoplastic*
Female ; Mice ; Animals ; Lymphatic Metastasis ; Mice, Nude ; Prognosis ; Drug Resistance ; Cell Proliferation ; Cell Line, Tumor ; Transcription Factors
Czasopismo naukowe
Tytuł:
Identification and clinical validation of key genes as the potential biomarkers in colorectal adenoma.
Autorzy:
Wang B; Digestive Endoscopy Department, The First Affiliated Hospital With Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Zhang J; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
Wang X; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
Zhao L; Digestive Endoscopy Department, The First Affiliated Hospital With Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Wang Y; Digestive Endoscopy Department, The First Affiliated Hospital With Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Fan Z; Digestive Endoscopy Department, The First Affiliated Hospital With Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Liu L; Digestive Endoscopy Department, The First Affiliated Hospital With Nanjing Medical University and Jiangsu Province Hospital, Nanjing, Jiangsu, China. .
Gao W; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 11; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Gene Expression Regulation, Neoplastic*
Humans ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Computational Biology/methods ; Gene Expression Profiling/methods ; Protein Interaction Maps/genetics ; Transcriptome ; Adenoma/diagnosis ; Adenoma/genetics ; Adenoma/metabolism ; Colon/pathology
Czasopismo naukowe
Tytuł:
miR-140-3p attenuated the tumorigenesis of multiple myeloma via attenuating BZW2.
Autorzy:
Long X; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Li J; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Wen F; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Cao Y; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Luo Z; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Luo C; Department of Hematology, The 1st Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 173-180.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
DNA-Binding Proteins/*genetics
MicroRNAs/*genetics
Multiple Myeloma/*genetics
Animals ; Carcinogenesis/genetics ; Cell Line, Tumor ; Humans ; Mice, Inbred BALB C ; Mice
Czasopismo naukowe
Tytuł:
Identification of differentially expressed genes and pathways in kidney of ANCA-associated vasculitis by integrated bioinformatics analysis.
Autorzy:
Deng X; Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Gao J; Department of Human Anantomy, Nanjing Medical University, Nanjing, P. R. China.
Zhao F; Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2022 Dec; Vol. 44 (1), pp. 204-216.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*genetics
Computational Biology/*methods
Kidney/*pathology
Protein Interaction Maps/*genetics
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology ; Biomarkers, Tumor/genetics ; Gene Expression Profiling ; Gene Regulatory Networks ; Humans ; Prognosis ; Software
Czasopismo naukowe
Tytuł:
A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma.
Autorzy:
Ma K; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Zhang P; Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
Xia Y; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Dong L; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Li Y; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Liu L; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Liu Y; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China.
Wang Y; Department of Pediatrics, The Fifth Affiliated Hospital of Zhengzhou University, No. 3 Kangfuqian Street, Zhengzhou, China. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2022 Nov 23; Vol. 15 (1), pp. 242. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Neuroblastoma*/genetics
Humans ; Biomarkers, Tumor/genetics ; N-Myc Proto-Oncogene Protein/genetics ; Prognosis
Czasopismo naukowe
Tytuł:
MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer.
Autorzy:
Zeng Z; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.; Jiangxi Institute of Urology, Nanchang, 330000, China.
He W; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.; Jiangxi Institute of Urology, Nanchang, 330000, China.
Jiang Y; Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
Jiang H; Department of Ultrasound Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
Cheng X; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.; Jiangxi Institute of Urology, Nanchang, 330000, China.
Deng W; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.; Jiangxi Institute of Urology, Nanchang, 330000, China.
Zhou X; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
Zhang C; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
Wang G; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. .; Jiangxi Institute of Urology, Nanchang, 330000, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Nov 11; Vol. 22 (1), pp. 1162. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Prostatic Neoplasms*/pathology
Male ; Humans ; Prognosis ; Cell Line, Tumor ; Cell Proliferation/genetics
Czasopismo naukowe
Tytuł:
Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Autorzy:
Wang L; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Yao B; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Yang J; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Tian Z; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
He J; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Nov 04; Vol. 22 (1), pp. 1131. Date of Electronic Publication: 2022 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Thyroid Neoplasms*/pathology
Apoptosis*
Humans ; Nomograms ; Prognosis ; Thyroid Cancer, Papillary/pathology ; Tumor Microenvironment/genetics ; Copper
Czasopismo naukowe
Tytuł:
Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Autorzy:
Wang D; Department of Gastroenterology, People's Hospital of Longhua, NO.38 Jinglong Construction Road, Longhua District, 518109, Shenzhen, P.R. China.
Liufu J; Department of Gastroenterology, People's Hospital of Longhua, NO.38 Jinglong Construction Road, Longhua District, 518109, Shenzhen, P.R. China.
Yang Q; Department of Gastroenterology, People's Hospital of Longhua, NO.38 Jinglong Construction Road, Longhua District, 518109, Shenzhen, P.R. China.
Dai S; Department of Gastroenterology, People's Hospital of Longhua, NO.38 Jinglong Construction Road, Longhua District, 518109, Shenzhen, P.R. China.
Wang J; Department of Gastroenterology, Guangzhou First People's Hospital, 511458, Guangzhou, P.R. China.
Xie B; Department of Gastroenterology, People's Hospital of Longhua, NO.38 Jinglong Construction Road, Longhua District, 518109, Shenzhen, P.R. China. .
Pokaż więcej
Źródło:
Biology direct [Biol Direct] 2022 Nov 02; Vol. 17 (1), pp. 29. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Humans ; Biomarkers, Tumor/genetics ; Prognosis ; Kaplan-Meier Estimate ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism
Czasopismo naukowe
Tytuł:
Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
Autorzy:
Wang K; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Guan C; Department of Kidney Internal Medicine, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Yu J; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Chen X; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Shang X; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Mei S; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Feng X; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.
Zheng L; Department of Obstetrics and Gynecology, Taizhou Hospital Zhejiang Province, Wenzhou Medical University, Linhai, 317000 Zhejiang, China.; Department of Obstetrics and Gynecology, Shaoxing University, Shaoxing, 312000 Zhejiang, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Nov 02; Vol. 2022, pp. 9328972. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Ovarian Neoplasms*/pathology
Humans ; Female ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/pathology ; Prognosis ; Biomarkers ; Tumor Microenvironment ; Hepatocyte Nuclear Factor 3-alpha/genetics ; Hepatocyte Nuclear Factor 3-alpha/metabolism
Czasopismo naukowe
Tytuł:
Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
Autorzy:
Sharen G; Department of Pathology, Affiliated Hospital of Inner Mongolia Medical University & Department of Pathological Anatomy, College of Basic Medicine of Inner Mongolia Medical University, Hohhot, 010059, Inner Mongolia, China.
Li X; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Sun J; Department of Clinical Medicine Research Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, Inner Mongolia, China.
Zhang L; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Xi W; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Zhao X; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Han F; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Jia L; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
A R; Graduate School , Inner Mongolia Medical University, Hohhot, 010063, Inner Mongolia, China.
Cheng H; Department of Gastrointestinal Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, Inner Mongolia, China. .
Hou M; Department of Gastrointestinal Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, Inner Mongolia, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Oct 29; Vol. 20 (1), pp. 493. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Colorectal Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Biomarkers, Tumor/metabolism ; Neoplasm Proteins/metabolism ; GTPase-Activating Proteins/genetics
Czasopismo naukowe
Tytuł:
MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer.
Autorzy:
Wen P; Department of Pathophysiology, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China. wenpushuai_.; Biological Anthropology Institute, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China. wenpushuai_.
Wang H; Biological Anthropology Institute, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China.
Li Y; Department of Pathophysiology, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China.
Sui X; Department of Pathophysiology, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China.
Hou Z; Department of Pathophysiology, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China.
Guo X; Life Science Institute, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China.
Xue W; Department of Hematology-Oncology, Fuyang Sixth People's Hospital, Fuyang, 236000, China.
Liu D; Biological Anthropology Institute, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China. .
Wang Y; Life Science Institute, Jinzhou Medical University, No.40, Section 3, Songpo Road, Jinzhou, 121001, China. .
Gao J; Department of Ultrasonography, The First Affiliated Hospital, Jinzhou Medical University, No. 2, Section 5, Renmin Street, Jinzhou, 121001, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2022 Oct 28; Vol. 20 (1), pp. 170. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Video-Audio Media; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Colorectal Neoplasms*/pathology
Humans ; Wnt Signaling Pathway/genetics ; Carcinogenesis/genetics ; Cell Transformation, Neoplastic ; Cell Proliferation ; Cell Line, Tumor ; beta Catenin/metabolism ; Cell Movement/genetics
Czasopismo naukowe
Tytuł:
Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma.
Autorzy:
Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.
Li Y; Department of Nursing, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.
Li N; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.
Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.
Li Z; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province, P.R. China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Oct 13; Vol. 17 (10), pp. e0276120. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Glioma*/genetics
Glioma*/pathology
Histone Deacetylases/genetics ; Histone Deacetylases/metabolism ; Humans ; Immunity ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Development of a Hallmark Pathway-Related Gene Signature Associated with Immune Response for Lower Grade Gliomas.
Autorzy:
Lai G; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Zhong X; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Liu H; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Deng J; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Li K; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Xie B; Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University, Yixue Road, Chongqing 400016, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 09; Vol. 23 (19). Date of Electronic Publication: 2022 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Glioma*/genetics
Glioma*/metabolism
Glioma*/therapy
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Humans ; Immunity ; RNA, Messenger/genetics
Czasopismo naukowe
Tytuł:
Identification of inflammatory-related gene signatures to predict prognosis of endometrial carcinoma.
Autorzy:
Chen L; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.
Zhu G; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.
Liu Y; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.
Shao Y; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.
Pan B; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.
Zheng J; Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China. .
Pokaż więcej
Źródło:
BMC genomic data [BMC Genom Data] 2022 Oct 07; Vol. 23 (1), pp. 74. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Endometrial Neoplasms*/diagnosis
Gene Expression Regulation, Neoplastic*/genetics
Biomarkers, Tumor/genetics ; Computational Biology ; Female ; Humans ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer.
Autorzy:
Hu K; Department of Hepatobiliary Surgery, Xiangya Hospital, Central South University, Changsha, 410008 Hunan, China.
Zhang X; Departments of Burn and Plastic, Ningxiang People's Hospital, Hunan University of Chinese Medicine, Changsha, 410600 Hunan, China.
Zhou L; Department of Anesthesiology, Third Xiangya Hospital of Central South University, Changsha, 410008 Hunan, China.
Li J; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008 Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008 Hunan, China.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2022 Sep 29; Vol. 2022, pp. 3205040. Date of Electronic Publication: 2022 Sep 29 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Ovarian Neoplasms*/metabolism
Carcinoma, Ovarian Epithelial/genetics ; Cell Line, Tumor ; Cell Proliferation/genetics ; Female ; Humans ; Prion Proteins/genetics ; Prion Proteins/metabolism ; RNA, Messenger
Czasopismo naukowe
Tytuł:
Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Autorzy:
Chu M; Suzhou Stomatological Hospital, Suzhou 215000, China.
Zheng K; Department of Stomatology, Wuxi No.2 People's Hospital, Wuxi 214000, China.
Li X; Suzhou Stomatological Hospital, Suzhou 215000, China.
Luo Z; Suzhou Stomatological Hospital, Suzhou 215000, China.
Yang X; Genetics and Cellular Engineering Group, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum Munich, Neuherberg 85764, Germany.
Wei C; Suzhou Stomatological Hospital, Suzhou 215000, China.
Pokaż więcej
Źródło:
Analytical cellular pathology (Amsterdam) [Anal Cell Pathol (Amst)] 2022 Sep 19; Vol. 2022, pp. 2371057. Date of Electronic Publication: 2022 Sep 19 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Head and Neck Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Computational Biology ; Glucose Transporter Type 3/genetics ; Glucose Transporter Type 3/metabolism ; Humans ; Squamous Cell Carcinoma of Head and Neck/genetics
Czasopismo naukowe
Tytuł:
MicroRNA-570 targets the HSP chaperone network, increases proteotoxic stress and inhibits mammary tumor cell migration.
Autorzy:
Okusha Y; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. .; JSPS Overseas Research Fellow, Tokyo, 102-0083, Japan. .
Guerrero-Gimenez ME; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Institute of Biochemistry and Biotechnology, School of Medicine, National University of Cuyo, 5500, Mendoza, Argentina.
Lang BJ; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Borges TJ; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA.
Stevenson MA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Truman AW; Department of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Calderwood SK; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Sep 16; Vol. 12 (1), pp. 15582. Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Regulation, Neoplastic*
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Movement ; Humans ; Molecular Chaperones/genetics ; Molecular Chaperones/metabolism ; Neoplasm Invasiveness/genetics ; Untranslated Regions
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies